Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Gates Foundation

Assessing Global Health Research and Development Financing and Policy Innovations

Last update: Jul 23, 2015 Last update: Jul 23, 2015

Details

Locations:Worldwide
Start Date:Jan 1, 2010
End Date:Dec 31, 2010
Sectors:Health, Research & Innovation
 Health, Research & Innovation
Categories:Consulting services
Funding Agencies:
Gates Foundation
Date posted:Nov 29, 2013

Associated funding

Associated experts

Description

HLSP assessed a group of proposed pooled funding mechanisms for research and development for neglected diseases. These mechanisms include the Industry R&D Facilitation Fund (IRFF), the Fund for Research for Neglected Diseases (FRIND) and the Product Development Partnership Financing Facility (PDP-FF).

Through in-depth qualitative and quantitative analysis, HLSP identified the contexts in which the proposals are likely to be successful, assessing the funding mechanisms’ ability to raise additional funding and their capacity to improve funding effectiveness and efficiency.

Technical areas:

  • Access to medicines
  • Private sector
  • TB, malaria and other communicable diseases.

Client: Results for Development (for the Bill and Melinda Gates Foundation).

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.
Learn more about our membership benefits
Print